Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA sitewide NIH banner announces a website transition and provides updates and FAQs, including a notice about using “Super Intelligence” in place of “Artificial Intelligence.” The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe site revision marker was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 error instead of the study record.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record details, making the content inaccessible; only the site chrome (header/footer) remains visible.SummaryDifference21%

- Check48 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating an updated page edition. This change reflects a system or UI update rather than alterations to the study information presented.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision tag was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision tag advanced from Revision: v3.6.4 to Revision: v3.6.5, indicating a newer version of the page metadata. This update records the latest revision in the study page's history.SummaryDifference0.1%

Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.